http://www.acc.org/Feed?clinicalTopicID=45d25f86-5c8b-42a6-818b-c3998baad19a Clinical Topic Feed: Lipid Metabolism en /Latest-in-Cardiology/Journal-Scans/2026/06/08/17/44/SOGALDI-PEF Patients with low plasma renin levels had a more pronounced blood pressure (BP) reduction with spironolactone/dapagliflozin vs. dapagliflozin alone, in addition to seeing a more favorable impact on cardiovascular structure and function, while aldosterone levels exhibited no predictive value in treatment response... 1781118900000 Articles and Stories /Latest-in-Cardiology/Journal-Scans/2026/06/08/17/44/First-Ever-Guideline-Addresses-CKM-Syndrome The new 2026 AHA/ACC/ADA/ASN Guideline for the Prevention, Detection, Evaluation, and Management of Cardiovascular-Kidney-Metabolic (CKM) Syndrome is the first ever to address the "interrelated condition characterized by the interconnections among metabolic risk factors (including obesity and type 2 diabetes)... 1781028000000 Articles and Stories https://www.jacc.org/doi/10.1016/j.jacc.2026.03.056 1781028000000 Guidelines /Latest-in-Cardiology/Journal-Scans/2026/06/03/20/12/New-Research Three new studies published in Circulation highlight advances in lipid-lowering therapy, with early-stage data supporting a first-in-class oral PCSK9 inhibitor and two separate analyses showing that evolocumab reduces major cardiovascular events across a range of high-risk patients, including those with elevated Lp(a) and those with prior PCI but no history of MI. 1780519500000 Articles and Stories /Latest-in-Cardiology/Journal-Scans/2026/06/02/15/27/New-Studies-Point-to-Emerging-Strategies-For-HFrEF Results from two early studies published in NEJM could have important implications for patients with heart failure (HF) and reduced LVEF and for adults with heterozygous familial hypercholesterolemia (HFH) or premature coronary artery disease, respectively. 1780493820000 Articles and Stories /Latest-in-Cardiology/Articles/2026/05/27/15/57/eagles-eye-view-27may2026 In this week’s View, Dr. Eagle examines recent research into maintaining weight loss with tirzepatide. He then offers insights into the new dyslipidemia guidelines, including addressing reproductive and hormone risk factors in cardiovascular risk assessment. 1779898740000 Articles and Stories /Latest-in-Cardiology/Journal-Scans/2026/05/18/18/10/New-Studies-Add-to-Evidence Treatment of patients following ischemic stroke was the focus of three separate studies published in JAMA, two of which involved use of intravenous tenecteplase and the other involving thrombectomy plus intra-arterial alteplase. 1779219300000 Articles and Stories /Latest-in-Cardiology/Articles/2026/05/19/15/49/JACC-Spotlight-Issue-2026-Dyslipidemia-Guideline A special JACC Spotlight Issue supporting the recently published 2026 ACC/AHA Guideline on the Management of Dyslipidemia, offers commentaries that provide a comprehensive overview of the new guideline recommendations and expert insights into understanding the science behind the recommendations... 1779206040000 Articles and Stories /Latest-in-Cardiology/Articles/2026/05/01/01/JACC-in-a-Flash Featured topics and Editors' Picks from all of ACC's JACC Journals. 1777637400000 Articles and Stories /Latest-in-Cardiology/Articles/2026/05/01/01/Journal-Wrap The hottest research from various peer-reviewed journals – handpicked weekly by the ACC. 1777637340000 Articles and Stories